Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 2, 1999, Pages 287-292

  Brada, Michael ^a,d,e   Sharpe, Geoffrey ^a   Rajan, Balakrishnan ^a,c   Britton, Juliet ^a   Wilkins, Peter R ^a   Guerrero, Douglas ^a   Hines, Frances ^a   Traish, Daphne ^a   Ashley, Susan ^b  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ATKINSON MORLEY S HOSPITAL   (United Kingdom)

^c Regional Cancer Center   (India)

^d REGIONAL CANCER CENTRE   (India)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Accelerated radiotherapy; High grade glioma

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; GLIOBLASTOMA; GLIOMA; GLIOSARCOMA; HEALTH ECONOMICS; HUMAN; HUMAN TISSUE; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; TREATMENT PLANNING;

ADULT; AGED; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033556691     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00390-3     Document Type: Article

References (19)

1. Kristiansen K., Hagen S., Kollevold T., Torvik A., Holme I., Nesbakken R., Hatlevoll R., Lindgren M., Brun A., Lindgren S., Notter G., Andersen A.P., Elgen K. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A Prospective Multicenter Trial of the Scandinavian Glioblastoma Study group. Cancer. 47:1981;649-652.
2. Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Norrell HA, Owens G, Ransohoff J, Wilson CB, WC, Gehan EA, Strike TA. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978;49:333-343.
3. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer. 64:1991;769-774.
4. Brada M., Thomas G., Elyan S., James N., Hines F., Ashley S., Marsh H., Bell B.A., Stenning S. Improving the acceptability of high dose radiotherapy by reducing the duration of treatment accelerated radiotherapy in high grade glioma . Br J Cancer. 71:1995;1330-1334.
5. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of grades 3 and 4 astrocytomas A report from the MRC Working Party on misonidazole in gliomas . Br J Radiol. 56:1983;673-682.
6. Brazil L., Thomas R., Laing R., Hines F., Guerrero D., Ashley S., Brada M. Verbally administered Barthel Index as functional assessment in brain tumour patients. J Neuroonocol. 34:1997;187-192.
7. Shepherd S.F., Laing R.W., Cosgrove V.P., Warrington A.P., Hines F., Ashley S.E., Brada M. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys. 37:1997;393-398.
8. Cox D.R. Regression models and life tables. J R Stat Soc (B). 34:1972;187-202.
9. Curran W.J., Scott C.B., Horton J., Nelson J.S., Weinstein A.S., Fischbach J., Chang C.H., Rotman M., Asbell S.O., Krisch R.E., Nelson D.F. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst. 85:1993;704-710.
10. Shapiro W.R. Therapy of adult malignant brain tumours What have the clinical trials taught us? Semin Oncol. 13:1986;38-45.
11. Stenning S., Freedman L.S., Bleehen N.M. Prognostic factors for high grade glioma Development of a prognostic index . J of Neuro Oncol. 9:1990;47-55.
12. Buatti J.M., Marcus R.B., Mendenhall W.M., Friedman W.A., Bova F.J. Accelerated hyperfractionated radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys. 34:1996;785-792.
13. Gonzalez D.G., Menten J., Bosch D.A., van der Schueren E., Troost D., Hulshof M.C., Bernier J. Accelerated radiotherapy in glioblastoma multiforme a dose searching prospective study . Radiother Oncol. 32:1994;98-105.
14. Keim H., Potthoff P.C., Schmidt K., Schiebusch M., Neiss A., Trott K.R. Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. Radiother Oncol. 9:1987;21-26.
15. Levin V.A., Maor M.H., Thall P.F., Yung W.K.A., Bruner J., Sawaya R., Kyritsis A.P., Leeds N., Woo S., Rodriguez L., et al. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 33:1995;357-364.
16. Curran W.J., Scott C.B., Nelson J.S., Weinstein A.S., Phillips T.L., Murray K., Fischbach A.J., Yakar D., Schwade J.G., Powlis W.D., Nelson D.F. A randomized trial of accelerated hyperfractionated radiation therapy and bis chlorethyl nitrosourea for malignant glioma. Cancer. 70:1992;2909-2917.
17. Nelson D.R., Curran W.J., Scott C., Nelson J.S., Weinstein A.S., Ahmad K., Constine L.S., Murray K., Powlis W.D., Mohiuddin M., Fischbach J. Hyperfractionated radiation therapy and bis chlorethyl nitrosourea in the treatment of malignant glioma - possible advantage observed at 72.0 Gy in 1.2 Gy BID fractions Report of the radiation therapy oncology group protocol 8302 . Int J Radiat Oncol Biol Phys. 25:1993;193-207.
18. Sullivan F.J., Herscher L.L., Cook J.A., Smith J., Steinberg S.M., Epstein A.H., Oldfield E.H., Goffman T.E., Kinsella T.J., Mitchell J.B., Glatstein E. National Cancer Institute (phase II) study of high grade glioma treated with accelerated hyperfractionated radiation and idodeoxyuridine Results in anaplastic astrocytoma . Int J Radiat Oncol Biol Phys. 30:1994;583-590.
19. Faithfull S., Brada M. Somnolence syndrome in adults following cranial irradiation for primary brain tumours. Clin Oncol. 10:1998;250-254.